The hunt for dementia’s hidden clues
Srikanth
About the Authors
-
Velandai srikanth
Professor, Peninsula Clinical School, Director, National Centre for Healthy Ageing
Velandai is an NHMRC Practitioner Fellow, and has been the recipient of continuous fellowships from the NHMRC and the Heart Foundation over the past 10 years. His program of research spans several aspects of ageing health. His primary interest is in the study of risk factors and mechanisms underlying dementia, particularly with respect to vascular and metabolic health. He has also led the field in the study of the impact of brain ageing on impaired mobility and the risk of falls, and in the link between brain ageing, gait and cognition. He actively collaborates in large scale initiatives in the genetics of brain ageing and risk stratification for the secondary prevention of stroke.
-
Joanne ryan
Associate Professor (Research), Chronic Disease and Ageing, School of Public Health and Preventive Medicine, Monash University
Joanne heads the Biological Neuropsychiatry and Dementia research unit in the School of Public Health and Preventive Medicine. Joanne's research in neuropsychiatric disorders is focused on preventative interventions and risk prediction, and understanding the biological underpinnings of these disorders, as well as biomarker identification (including epigenetics). Her research interests include dementia; cognitive ageing; epigenetics; depression; stress/trauma; biological underpinnings and frailty.
-
Adeel razi
Associate Professor (Research), Psychology, Turner Institute for Brain and Mental Health, Monash University
Adeel is head of the Computational Neuroscience Laboratory, performing cross-disciplinary research combining engineering, physics, and machine-learning approaches to answer questions that are motivated by and grounded in neurobiology. The research program’s priority areas include the development of neuroscience-inspired artificial intelligence schemes to understand how brain performs reasoning, learning and planning and the use of classical psychedelics (e.g. LSD and Psilocybin) in combination with computational modelling to understand neural mechanisms underlying altered states of consciousness.
-
Amy brodtmann
Professor, Department of Neuroscience, Victorian Heart Institute
Amy examines vascular contributions to late-life cognition. She’s interested in modifiable risk and identifying interventions to prevent post-stroke dementia and pathological cognitive ageing. She aims to improve the diagnostic pathway for people with dementia and their carers by developing novel biomarkers.
Other stories you might like
-
Could the shingles vaccine offer a new defence against dementia?
Already celebrated for their success in preventing infectious diseases, vaccines may also hold the key to unlocking a new era of cognitive health.
-
Does menopause hormone therapy increase or decrease your risk of dementia?
Some studies say menopause hormone therapy increases the risk of dementia, while others say it reduces it. Here’s how to make sense of the conflicting results.
-
Navigating dementia diagnosis and care
There’s an urgent need to create clearer, easier and more supportive pathways for Australians diagnosed with dementia.
-
The test that could change sport-related concussion protocols
A blood test that accurately detects the ongoing effects of sport-related concussion has the potential to help pinpoint when a player can safely return.